GNOM241220C12000
- 0.00
- 0.000.00%
Global X Fds Genomics & Biotechnology Etf Newsroom
Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
Trending Stocks This Week as Holiday Season Begins With Thanksgiving Break
Bernstein Maintains Market Perform on Arrowhead Pharma, Lowers Price Target to $24
Cathie Wood Sees Tesla As 'Largest AI Project On Earth' — Here's Why She's Not Worried About Tech Investments
Iris Energy, Arrowhead Pharmaceuticals, Urban Outfitters And Other Big Stocks Moving Higher On Wednesday
Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%
Natera Announces Its Prospera Lung Test Has Met Coverage Requirements From The Centers For Medicare & Medicaid Services' Molecular Diagnostics Services Program For Single Lung Transplant Recipients; This Coverage Applies To SLT Patients In The...
Arrowhead Pharmaceuticals Shares Are Trading Higher. Chardan Capital Maintained a Buy Rating on the Stock.
Chardan Capital Maintains Buy on Arrowhead Pharma, Maintains $60 Price Target
Arrowhead Pharma Analyst Ratings
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
Needham Maintains Buy on Sarepta Therapeutics, Lowers Price Target to $202
Sarepta Therapeutics Analyst Ratings
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Arrowhead Pharma FY 2024 GAAP EPS $(5.00) Misses $(4.45) Estimate, Sales $3.551M Miss $74.932M Estimate
Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM
Expert Outlook: Agilent Technologies Through The Eyes Of 4 Analysts
Stocks Mixed Ahead Of Fed Minutes, Mexican Peso Tumbles To Over 2-Year Lows On Tariffs Fears: What's Driving Markets Tuesday?
Dyne, Avidity Initiated at Outperform by RBC on DM1 Drugs